Side-by-side comparison of AI visibility scores, market position, and capabilities
Fort Lauderdale heart rate-monitored interval training franchise with 1,500+ studios and 1.5M+ members; $400M raised competing with F45 and Barry's for boutique fitness at $59-$159/month technology-tracked group workouts.
Orangetheory Fitness is a Fort Lauderdale-based boutique fitness franchise delivering science-based, heart rate-monitored group interval training workouts — 60-minute sessions combining treadmill cardio, rowing, and weight-training floor work structured around heart rate zones displayed on studio monitors, targeting the "Orange Zone" (84-91% max heart rate) that produces excess post-exercise oxygen consumption (EPOC) for extended calorie burn. Founded in 2010 by Ellen Latham and backed with $400 million raised, Orangetheory operates 1,500+ franchise studios across 25+ countries serving over 1.5 million members paying $59-$159/month for membership plans.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.